About FDA

Frequently Used Guidance Documents

ODEIII specific guidances

Regulatory guidances

 Electronic Submissions Guidances

Safety Guidances

Labeling Guidances

Other, specific therapeutics, products Guidances

 

Return to the Office of Drug Evaluation III (ODEIII) page

 

 
 

Page Last Updated: 12/17/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.